Protective effect of pyrroloquinoline quinone against Aβ-induced neurotoxicity in human neuroblastoma SH-SY5Y cells

Neuroscience Letters

Volumn 464, Issue 3, 2009, Pages 165-169

  Zhang, Jun Jing ^a   Zhang, Rui Fang ^a   Meng, Xing Kai ^a  

^a INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

Amyloid peptide; Alzheimer's disease; Apoptosis; Pyrroloquinoline quinone

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; PYRROLOQUINOLINEQUINONE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID BETA-PROTEIN; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PQQ COFACTOR; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 70149088558     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.08.037     Document Type: Article

References (42)

1. Aizenman E., Hartnett K., Zhong C., Gallop P., and Rosenberg P. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-d-aspartate receptor redox modulatory site. J. Neurosci. 12 (1992) 2362-2369
2. Alexandrova M., and Bochev P. Oxidative stress during the chronic phase after stroke. Free Radic. Biol. Med. 39 (2005) 297-316
3. Allen J., Eldadah B., Huang X., Knoblach S., and Faden A. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J. Neurosci. Res. 65 (2001) 45-53
4. Bastianetto S., Ramassamy C., Doré S., Christen Y., Poirier J., and Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur. J. Neurosci. 12 (2000) 1882-1890
5. Behl C., Davis J., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
6. Butterfield D., Drake J., Pocernich C., and Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 7 (2001) 548-554
7. Doré S., Kar S., and Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4772-4777
8. Feng Z., and Zhang J. Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells. J. Pineal Res. 37 (2004) 257-266
9. Fukui K., Takatsu H., Shinkai T., Suzuki S., Abe K., and Urano S. Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J. Alzheimers Dis. 8 (2005) 299-309
10. Hamagishi Y., Murata S., Kamei H., Oki T., Adachi O., and Ameyama M. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J. Pharmacol. Exp. Ther. 255 (1990) 980-985
11. Hara H., Hiramatsu H., and Adachi T. Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem. Res. 32 (2007) 489-495
12. Hardy J., and Selkoe D. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
13. Harkany T., Hortobágyi T., Sasvári M., Kónya C., Penke B., Luiten P., and Nyakas C. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 23 (1999) 963-1008
14. He K., Nukada H., Urakami T., and Murphy M. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem. Pharmacol. 65 (2003) 67-74
15. Hensley K., Carney J., Mattson M., Aksenova M., Harris M., Wu J., Floyd R., and Butterfield D. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3270-3274
16. Huang J., and May J. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res. 1097 (2006) 52-58
17. Jang J., and Surh Y. Beta-amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase. Ann. N.Y. Acad. Sci. 973 (2002) 228-236
18. Jensen F., Gardner G., Williams A., Gallop P., Aizenman E., and Rosenberg P. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience 62 (1994) 399-406
19. Kadowaki H., Nishitoh H., Urano F., Sadamitsu C., Matsuzawa A., Takeda K., Masutani H., Yodoi J., Urano Y., Nagano T., and Ichijo H. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 12 (2005) 19-24
20. Kasahara T., and Kato T. Nutritional biochemistry: a new redox-cofactor vitamin for mammals. Nature 422 (2003) 832
21. Kumazawa T., Sato K., Seno H., Ishii A., and Suzuki O. Levels of pyrroloquinoline quinone in various foods. Biochem. J. 307 Pt 2 (1995) 331-333
22. Kumazawa T., Seno H., Urakami T., Matsumoto T., and Suzuki O. Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim. Biophys. Acta 1156 (1992) 62-66
23. Lin Y., Liu A., Wu H., Westenbroek C., Song Q., Yu H., Ter Horst G., and Li X. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta(25-35)-induced reduction in BPRP in PC12 cells. Biochem. Biophys. Res. Commun. 348 (2006) 593-599
24. Longpré F., Garneau P., Christen Y., and Ramassamy C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic. Biol. Med. 41 (2006) 1781-1794
25. Loo D., Copani A., Pike C., Whittemore E., Walencewicz A., and Cotman C. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7951-7955
26. Markesbery W. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23 (1997) 134-147
27. Nunome K., Miyazaki S., Nakano M., Iguchi-Ariga S., and Ariga H. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol. Pharm. Bull. 31 (2008) 1321-1326
28. Park S., Kim H., Cho E., Kwon B., Phark S., Hwang K., and Sul D. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem. Toxicol. 46 (2008) 2881-2887
29. Salisbury S., Forrest H., Cruse W., and Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature 280 (1979) 843-844
30. Sanchez R., Wang C., Gardner G., Orlando L., Tauck D., Rosenberg P., Aizenman E., and Jensen F. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J. Neurosci. 20 (2000) 2409-2417
31. Scanlon J., Aizenman E., and Reynolds I. Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur. J. Pharmacol. 326 (1997) 67-74
32. Selkoe D. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N.Y. Acad. Sci. 924 (2000) 17-25
33. Su J., Zhao M., Anderson A., Srinivasan A., and Cotman C. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res. 898 (2001) 350-357
34. Tsuchida T., Yasuyama T., Higuchi K., Watanabe A., Urakami T., Akaike T., Sato K., and Maeda H. The protective effect of pyrroloquinoline quinone and its derivatives against carbon tetrachloride-induced liver injury of rats. J. Gastroenterol. Hepatol. 8 (1993) 342-347
35. Wei C., Jia J., Liang P., and Guan Y. Ginsenoside Rg1 attenuates beta-amyloid-induced apoptosis in mutant PS1 M146L cells. Neurosci. Lett. 443 (2008) 145-149
36. Xiao X., Zhang H., and Tang X. Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J. Neurosci. Res. 67 (2002) 30-36
37. Yan X., Qiao J., Dou Y., and Qiao Z. Beta-amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons. Neuroscience 92 (1999) 177-184
38. Yang J., Liu X., Bhalla K., Kim C., Ibrado A., Cai J., Peng T., Jones D., and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
39. Zhang P., Xu Y., Sun J., Li X., Wang L., and Jin L. Protection of pyrroloquinoline quinone against methylmercury-induced neurotoxicity via reducing oxidative stress. Free Radic. Res. 43 (2009) 224-233
40. Zhang Y., Feustel P., and Kimelberg H. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res. 1094 (2006) 200-206
41. Zhang Y., and Rosenberg P. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur. J. Neurosci. 16 (2002) 1015-1024
42. Zhu B., Zhou H., Teerlink J., and Karliner J. Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc. Drugs Ther. 18 (2004) 421-431